Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates. Solomon, B., Felip, E., Bar, J., Berchem, G., Bazhenova, L., Saintigny, P., Girard, N., Sulaiman, R., Bresson, C., Wunder, F., & others In CANCER RESEARCH, volume 79, 2019. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA ….
bibtex   
@inproceedings{solomon2019survival,
  title={Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates},
  author={Solomon, Benjamin and Felip, Enriqueta and Bar, Jair and Berchem, Guy and Bazhenova, Lyudmila and Saintigny, Pierre and Girard, Nicolas and Sulaiman, Raed and Bresson, Catherine and Wunder, Fanny and others},
  booktitle={CANCER RESEARCH},
  volume={79},
  number={13},
  year={2019},
  organization={AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA~…}
}

Downloads: 0